Orthofix Medical Inc. (OFIX) Stock Competitors & Peer Comparison

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, OFIX is priced at $9.61, while BSX-PA trades at $122.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, OFIX's ROE is -0.13%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, OFIX is more volatile compared to BSX-PA. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check BSX-PA's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, ABT has a market cap of 151.5B. Regarding current trading prices, OFIX is priced at $9.61, while ABT trades at $86.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas ABT's P/E ratio is 24.36. In terms of profitability, OFIX's ROE is -0.13%, compared to ABT's ROE of +0.12%. Regarding short-term risk, OFIX is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check ABT's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, ISRG has a market cap of 142.5B. Regarding current trading prices, OFIX is priced at $9.61, while ISRG trades at $399.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas ISRG's P/E ratio is 48.76. In terms of profitability, OFIX's ROE is -0.13%, compared to ISRG's ROE of +0.17%. Regarding short-term risk, OFIX is more volatile compared to ISRG. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check ISRG's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, SYK has a market cap of 112.5B. Regarding current trading prices, OFIX is priced at $9.61, while SYK trades at $292.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas SYK's P/E ratio is 34.00. In terms of profitability, OFIX's ROE is -0.13%, compared to SYK's ROE of +0.15%. Regarding short-term risk, OFIX is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check SYK's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, MDT has a market cap of 94.7B. Regarding current trading prices, OFIX is priced at $9.61, while MDT trades at $77.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas MDT's P/E ratio is 20.60. In terms of profitability, OFIX's ROE is -0.13%, compared to MDT's ROE of +0.10%. Regarding short-term risk, OFIX is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check MDT's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, BSX has a market cap of 70.9B. Regarding current trading prices, OFIX is priced at $9.61, while BSX trades at $47.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas BSX's P/E ratio is 19.95. In terms of profitability, OFIX's ROE is -0.13%, compared to BSX's ROE of +0.15%. Regarding short-term risk, OFIX is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check BSX's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, BRKRP has a market cap of 65B. Regarding current trading prices, OFIX is priced at $9.61, while BRKRP trades at $434.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas BRKRP's P/E ratio is N/A. In terms of profitability, OFIX's ROE is -0.13%, compared to BRKRP's ROE of -0.01%. Regarding short-term risk, OFIX is more volatile compared to BRKRP. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check BRKRP's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, EW has a market cap of 50.5B. Regarding current trading prices, OFIX is priced at $9.61, while EW trades at $86.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas EW's P/E ratio is 47.38. In terms of profitability, OFIX's ROE is -0.13%, compared to EW's ROE of +0.11%. Regarding short-term risk, OFIX is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check EW's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, DXCM has a market cap of 28.3B. Regarding current trading prices, OFIX is priced at $9.61, while DXCM trades at $72.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas DXCM's P/E ratio is 31.52. In terms of profitability, OFIX's ROE is -0.13%, compared to DXCM's ROE of +0.34%. Regarding short-term risk, OFIX is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check DXCM's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, RMD has a market cap of 26.5B. Regarding current trading prices, OFIX is priced at $9.61, while RMD trades at $186.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas RMD's P/E ratio is 17.64. In terms of profitability, OFIX's ROE is -0.13%, compared to RMD's ROE of +0.24%. Regarding short-term risk, OFIX is less volatile compared to RMD. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check RMD's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, PHG has a market cap of 24.2B. Regarding current trading prices, OFIX is priced at $9.61, while PHG trades at $25.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas PHG's P/E ratio is 21.92. In terms of profitability, OFIX's ROE is -0.13%, compared to PHG's ROE of +0.09%. Regarding short-term risk, OFIX is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check PHG's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, STE has a market cap of 20.6B. Regarding current trading prices, OFIX is priced at $9.61, while STE trades at $210.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas STE's P/E ratio is 26.46. In terms of profitability, OFIX's ROE is -0.13%, compared to STE's ROE of +0.11%. Regarding short-term risk, OFIX is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check STE's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, OFIX is priced at $9.61, while ABMD trades at $381.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas ABMD's P/E ratio is 65.36. In terms of profitability, OFIX's ROE is -0.13%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, OFIX is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check ABMD's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, ZBH has a market cap of 16.2B. Regarding current trading prices, OFIX is priced at $9.61, while ZBH trades at $84.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas ZBH's P/E ratio is 21.70. In terms of profitability, OFIX's ROE is -0.13%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, OFIX is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check ZBH's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, OFIX is priced at $9.61, while SWAV trades at $334.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas SWAV's P/E ratio is 78.76. In terms of profitability, OFIX's ROE is -0.13%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, OFIX is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check SWAV's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, PEN has a market cap of 12.5B. Regarding current trading prices, OFIX is priced at $9.61, while PEN trades at $319.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas PEN's P/E ratio is 73.60. In terms of profitability, OFIX's ROE is -0.13%, compared to PEN's ROE of +0.12%. Regarding short-term risk, OFIX is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check PEN's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, SNN has a market cap of 12.5B. Regarding current trading prices, OFIX is priced at $9.61, while SNN trades at $29.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas SNN's P/E ratio is 20.55. In terms of profitability, OFIX's ROE is -0.13%, compared to SNN's ROE of +0.12%. Regarding short-term risk, OFIX is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check SNN's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, ALGN has a market cap of 11.9B. Regarding current trading prices, OFIX is priced at $9.61, while ALGN trades at $165.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas ALGN's P/E ratio is 28.06. In terms of profitability, OFIX's ROE is -0.13%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, OFIX is more volatile compared to ALGN. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check ALGN's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, GMED has a market cap of 10.6B. Regarding current trading prices, OFIX is priced at $9.61, while GMED trades at $77.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas GMED's P/E ratio is 18.29. In terms of profitability, OFIX's ROE is -0.13%, compared to GMED's ROE of +0.13%. Regarding short-term risk, OFIX is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check GMED's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, PODD has a market cap of 9.9B. Regarding current trading prices, OFIX is priced at $9.61, while PODD trades at $141.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas PODD's P/E ratio is 33.28. In terms of profitability, OFIX's ROE is -0.13%, compared to PODD's ROE of +0.21%. Regarding short-term risk, OFIX is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check PODD's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, OFIX is priced at $9.61, while MASI trades at $178.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas MASI's P/E ratio is 44.35. In terms of profitability, OFIX's ROE is -0.13%, compared to MASI's ROE of +0.09%. Regarding short-term risk, OFIX is more volatile compared to MASI. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check MASI's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, BRKR has a market cap of 8.7B. Regarding current trading prices, OFIX is priced at $9.61, while BRKR trades at $58.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas BRKR's P/E ratio is -238.79. In terms of profitability, OFIX's ROE is -0.13%, compared to BRKR's ROE of -0.01%. Regarding short-term risk, OFIX is less volatile compared to BRKR. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check BRKR's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, BIO has a market cap of 8.3B. Regarding current trading prices, OFIX is priced at $9.61, while BIO trades at $304.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas BIO's P/E ratio is 51.01. In terms of profitability, OFIX's ROE is -0.13%, compared to BIO's ROE of +0.02%. Regarding short-term risk, OFIX is more volatile compared to BIO. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check BIO's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, BIO-B has a market cap of 8.2B. Regarding current trading prices, OFIX is priced at $9.61, while BIO-B trades at $304.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas BIO-B's P/E ratio is 50.64. In terms of profitability, OFIX's ROE is -0.13%, compared to BIO-B's ROE of +0.02%. Regarding short-term risk, OFIX is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check BIO-B's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, GKOS has a market cap of 6.5B. Regarding current trading prices, OFIX is priced at $9.61, while GKOS trades at $110.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas GKOS's P/E ratio is -33.62. In terms of profitability, OFIX's ROE is -0.13%, compared to GKOS's ROE of -0.26%. Regarding short-term risk, OFIX is less volatile compared to GKOS. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check GKOS's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, OFIX is priced at $9.61, while NARI trades at $79.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas NARI's P/E ratio is -59.24. In terms of profitability, OFIX's ROE is -0.13%, compared to NARI's ROE of -0.00%. Regarding short-term risk, OFIX is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check NARI's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, LIVN has a market cap of 4B. Regarding current trading prices, OFIX is priced at $9.61, while LIVN trades at $71.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas LIVN's P/E ratio is 37.41. In terms of profitability, OFIX's ROE is -0.13%, compared to LIVN's ROE of +0.09%. Regarding short-term risk, OFIX is less volatile compared to LIVN. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check LIVN's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, OFIX is priced at $9.61, while AXNX trades at $70.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas AXNX's P/E ratio is -709.80. In terms of profitability, OFIX's ROE is -0.13%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, OFIX is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check AXNX's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, IRTC has a market cap of 3.5B. Regarding current trading prices, OFIX is priced at $9.61, while IRTC trades at $102.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas IRTC's P/E ratio is -124.12. In terms of profitability, OFIX's ROE is -0.13%, compared to IRTC's ROE of -0.21%. Regarding short-term risk, OFIX is less volatile compared to IRTC. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check IRTC's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, ITGR has a market cap of 3.1B. Regarding current trading prices, OFIX is priced at $9.61, while ITGR trades at $90.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas ITGR's P/E ratio is 22.37. In terms of profitability, OFIX's ROE is -0.13%, compared to ITGR's ROE of +0.08%. Regarding short-term risk, OFIX is more volatile compared to ITGR. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check ITGR's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, TMDX has a market cap of 2.4B. Regarding current trading prices, OFIX is priced at $9.61, while TMDX trades at $67.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas TMDX's P/E ratio is 15.66. In terms of profitability, OFIX's ROE is -0.13%, compared to TMDX's ROE of +0.42%. Regarding short-term risk, OFIX is more volatile compared to TMDX. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check TMDX's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, AXGN has a market cap of 2.1B. Regarding current trading prices, OFIX is priced at $9.61, while AXGN trades at $39.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas AXGN's P/E ratio is -61.66. In terms of profitability, OFIX's ROE is -0.13%, compared to AXGN's ROE of -0.21%. Regarding short-term risk, OFIX is more volatile compared to AXGN. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check AXGN's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, OFIX is priced at $9.61, while NUVA trades at $39.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas NUVA's P/E ratio is 75.00. In terms of profitability, OFIX's ROE is -0.13%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, OFIX is less volatile compared to NUVA. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check NUVA's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, ESTA has a market cap of 2.1B. Regarding current trading prices, OFIX is priced at $9.61, while ESTA trades at $70.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas ESTA's P/E ratio is -47.93. In terms of profitability, OFIX's ROE is -0.13%, compared to ESTA's ROE of -2.26%. Regarding short-term risk, OFIX is more volatile compared to ESTA. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check ESTA's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, UFPT has a market cap of 1.7B. Regarding current trading prices, OFIX is priced at $9.61, while UFPT trades at $216.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas UFPT's P/E ratio is 24.68. In terms of profitability, OFIX's ROE is -0.13%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, OFIX is more volatile compared to UFPT. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check UFPT's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, PRCT has a market cap of 1.5B. Regarding current trading prices, OFIX is priced at $9.61, while PRCT trades at $26.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas PRCT's P/E ratio is -14.62. In terms of profitability, OFIX's ROE is -0.13%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, OFIX is more volatile compared to PRCT. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check PRCT's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, AHCO has a market cap of 1.3B. Regarding current trading prices, OFIX is priced at $9.61, while AHCO trades at $9.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas AHCO's P/E ratio is -16.36. In terms of profitability, OFIX's ROE is -0.13%, compared to AHCO's ROE of -0.05%. Regarding short-term risk, OFIX is more volatile compared to AHCO. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check AHCO's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, OFIX is priced at $9.61, while HSKA trades at $119.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas HSKA's P/E ratio is -62.49. In terms of profitability, OFIX's ROE is -0.13%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, OFIX is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check HSKA's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, TNDM has a market cap of 1.3B. Regarding current trading prices, OFIX is priced at $9.61, while TNDM trades at $18.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas TNDM's P/E ratio is -13.58. In terms of profitability, OFIX's ROE is -0.13%, compared to TNDM's ROE of -0.68%. Regarding short-term risk, OFIX is less volatile compared to TNDM. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check TNDM's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, ENOV has a market cap of 1.3B. Regarding current trading prices, OFIX is priced at $9.61, while ENOV trades at $21.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas ENOV's P/E ratio is -1.10. In terms of profitability, OFIX's ROE is -0.13%, compared to ENOV's ROE of -0.60%. Regarding short-term risk, OFIX is less volatile compared to ENOV. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check ENOV's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, IART has a market cap of 1.2B. Regarding current trading prices, OFIX is priced at $9.61, while IART trades at $15.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas IART's P/E ratio is -2.42. In terms of profitability, OFIX's ROE is -0.13%, compared to IART's ROE of -0.48%. Regarding short-term risk, OFIX is more volatile compared to IART. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check IART's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, BFLY has a market cap of 1.2B. Regarding current trading prices, OFIX is priced at $9.61, while BFLY trades at $4.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas BFLY's P/E ratio is -15.27. In terms of profitability, OFIX's ROE is -0.13%, compared to BFLY's ROE of -0.37%. Regarding short-term risk, OFIX is more volatile compared to BFLY. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check BFLY's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, OFIX is priced at $9.61, while AVNS trades at $25.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas AVNS's P/E ratio is -15.62. In terms of profitability, OFIX's ROE is -0.13%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, OFIX is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check AVNS's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, INSP has a market cap of 1.2B. Regarding current trading prices, OFIX is priced at $9.61, while INSP trades at $39.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas INSP's P/E ratio is 9.23. In terms of profitability, OFIX's ROE is -0.13%, compared to INSP's ROE of +0.18%. Regarding short-term risk, OFIX is less volatile compared to INSP. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check INSP's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, ATEC has a market cap of 1.2B. Regarding current trading prices, OFIX is priced at $9.61, while ATEC trades at $7.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas ATEC's P/E ratio is -9.01. In terms of profitability, OFIX's ROE is -0.13%, compared to ATEC's ROE of -4.43%. Regarding short-term risk, OFIX is less volatile compared to ATEC. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check ATEC's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, OFIX is priced at $9.61, while IRMD trades at $88.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas IRMD's P/E ratio is 49.10. In terms of profitability, OFIX's ROE is -0.13%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, OFIX is less volatile compared to IRMD. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check IRMD's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, OFIX is priced at $9.61, while SILK trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas SILK's P/E ratio is -18.96. In terms of profitability, OFIX's ROE is -0.13%, compared to SILK's ROE of -0.35%. Regarding short-term risk, OFIX is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check SILK's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, OFIX is priced at $9.61, while FNA trades at $13.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas FNA's P/E ratio is -19.83. In terms of profitability, OFIX's ROE is -0.13%, compared to FNA's ROE of -0.35%. Regarding short-term risk, OFIX is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check FNA's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, CNMD has a market cap of 1B. Regarding current trading prices, OFIX is priced at $9.61, while CNMD trades at $33.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas CNMD's P/E ratio is 19.12. In terms of profitability, OFIX's ROE is -0.13%, compared to CNMD's ROE of +0.05%. Regarding short-term risk, OFIX is less volatile compared to CNMD. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check CNMD's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, AORT has a market cap of 991.5M. Regarding current trading prices, OFIX is priced at $9.61, while AORT trades at $20.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas AORT's P/E ratio is 81.70. In terms of profitability, OFIX's ROE is -0.13%, compared to AORT's ROE of +0.03%. Regarding short-term risk, OFIX is less volatile compared to AORT. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check AORT's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, INMD has a market cap of 855.7M. Regarding current trading prices, OFIX is priced at $9.61, while INMD trades at $13.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas INMD's P/E ratio is 10.00. In terms of profitability, OFIX's ROE is -0.13%, compared to INMD's ROE of +0.13%. Regarding short-term risk, OFIX is more volatile compared to INMD. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check INMD's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, OFIX is priced at $9.61, while CSII trades at $20.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas CSII's P/E ratio is -20.83. In terms of profitability, OFIX's ROE is -0.13%, compared to CSII's ROE of -0.14%. Regarding short-term risk, OFIX is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check CSII's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, SSII has a market cap of 797.5M. Regarding current trading prices, OFIX is priced at $9.61, while SSII trades at $3.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas SSII's P/E ratio is -79.70. In terms of profitability, OFIX's ROE is -0.13%, compared to SSII's ROE of -0.23%. Regarding short-term risk, OFIX is less volatile compared to SSII. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check SSII's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, CRY has a market cap of 725.1M. Regarding current trading prices, OFIX is priced at $9.61, while CRY trades at $17.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas CRY's P/E ratio is 425.71. In terms of profitability, OFIX's ROE is -0.13%, compared to CRY's ROE of +0.03%. Regarding short-term risk, OFIX is less volatile compared to CRY. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check CRY's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, LMRI has a market cap of 721.6M. Regarding current trading prices, OFIX is priced at $9.61, while LMRI trades at $7.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas LMRI's P/E ratio is -19.26. In terms of profitability, OFIX's ROE is -0.13%, compared to LMRI's ROE of -0.15%. Regarding short-term risk, OFIX is less volatile compared to LMRI. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check LMRI's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, CBLL has a market cap of 663.2M. Regarding current trading prices, OFIX is priced at $9.61, while CBLL trades at $17.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas CBLL's P/E ratio is -10.79. In terms of profitability, OFIX's ROE is -0.13%, compared to CBLL's ROE of -0.38%. Regarding short-term risk, OFIX is more volatile compared to CBLL. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check CBLL's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, SIBN has a market cap of 621.3M. Regarding current trading prices, OFIX is priced at $9.61, while SIBN trades at $13.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas SIBN's P/E ratio is -35.92. In terms of profitability, OFIX's ROE is -0.13%, compared to SIBN's ROE of -0.10%. Regarding short-term risk, OFIX is less volatile compared to SIBN. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check SIBN's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, OFIX is priced at $9.61, while SRDX trades at $42.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas SRDX's P/E ratio is -34.66. In terms of profitability, OFIX's ROE is -0.13%, compared to SRDX's ROE of -0.13%. Regarding short-term risk, OFIX is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check SRDX's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, OFIX is priced at $9.61, while APEN trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas APEN's P/E ratio is -9.43. In terms of profitability, OFIX's ROE is -0.13%, compared to APEN's ROE of -0.85%. Regarding short-term risk, OFIX is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check APEN's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, BWAY has a market cap of 571.1M. Regarding current trading prices, OFIX is priced at $9.61, while BWAY trades at $14.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas BWAY's P/E ratio is 66.18. In terms of profitability, OFIX's ROE is -0.13%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, OFIX is more volatile compared to BWAY. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check BWAY's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, NPCE has a market cap of 555.4M. Regarding current trading prices, OFIX is priced at $9.61, while NPCE trades at $15.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas NPCE's P/E ratio is -25.06. In terms of profitability, OFIX's ROE is -0.13%, compared to NPCE's ROE of -1.21%. Regarding short-term risk, OFIX is less volatile compared to NPCE. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check NPCE's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, TCMD has a market cap of 550.6M. Regarding current trading prices, OFIX is priced at $9.61, while TCMD trades at $24.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas TCMD's P/E ratio is 28.06. In terms of profitability, OFIX's ROE is -0.13%, compared to TCMD's ROE of +0.10%. Regarding short-term risk, OFIX is less volatile compared to TCMD. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check TCMD's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, BVS has a market cap of 549.4M. Regarding current trading prices, OFIX is priced at $9.61, while BVS trades at $8.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas BVS's P/E ratio is 19.78. In terms of profitability, OFIX's ROE is -0.13%, compared to BVS's ROE of +0.16%. Regarding short-term risk, OFIX is less volatile compared to BVS. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check BVS's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, CTKB has a market cap of 541.1M. Regarding current trading prices, OFIX is priced at $9.61, while CTKB trades at $4.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas CTKB's P/E ratio is -7.22. In terms of profitability, OFIX's ROE is -0.13%, compared to CTKB's ROE of -0.21%. Regarding short-term risk, OFIX is less volatile compared to CTKB. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check CTKB's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, CERS has a market cap of 541M. Regarding current trading prices, OFIX is priced at $9.61, while CERS trades at $2.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas CERS's P/E ratio is -54.00. In terms of profitability, OFIX's ROE is -0.13%, compared to CERS's ROE of -0.15%. Regarding short-term risk, OFIX is less volatile compared to CERS. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check CERS's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, OFIX is priced at $9.61, while ZIMV trades at $18.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, OFIX's ROE is -0.13%, compared to ZIMV's ROE of -0.04%. Regarding short-term risk, OFIX is more volatile compared to ZIMV. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check ZIMV's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, PACB has a market cap of 490.8M. Regarding current trading prices, OFIX is priced at $9.61, while PACB trades at $1.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas PACB's P/E ratio is -3.85. In terms of profitability, OFIX's ROE is -0.13%, compared to PACB's ROE of -4.88%. Regarding short-term risk, OFIX is less volatile compared to PACB. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check PACB's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, LAB has a market cap of 452.8M. Regarding current trading prices, OFIX is priced at $9.61, while LAB trades at $1.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas LAB's P/E ratio is -8.92. In terms of profitability, OFIX's ROE is -0.13%, compared to LAB's ROE of -0.21%. Regarding short-term risk, OFIX is less volatile compared to LAB. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check LAB's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, KIDS has a market cap of 431.8M. Regarding current trading prices, OFIX is priced at $9.61, while KIDS trades at $16.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas KIDS's P/E ratio is -10.01. In terms of profitability, OFIX's ROE is -0.13%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, OFIX is less volatile compared to KIDS. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check KIDS's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, PMI has a market cap of 429M. Regarding current trading prices, OFIX is priced at $9.61, while PMI trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas PMI's P/E ratio is -0.36. In terms of profitability, OFIX's ROE is -0.13%, compared to PMI's ROE of +4.99%. Regarding short-term risk, OFIX is less volatile compared to PMI. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check PMI's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, VREX has a market cap of 418.5M. Regarding current trading prices, OFIX is priced at $9.61, while VREX trades at $9.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas VREX's P/E ratio is -4.97. In terms of profitability, OFIX's ROE is -0.13%, compared to VREX's ROE of -0.18%. Regarding short-term risk, OFIX is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check VREX's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, CLPT has a market cap of 371M. Regarding current trading prices, OFIX is priced at $9.61, while CLPT trades at $12.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas CLPT's P/E ratio is -12.37. In terms of profitability, OFIX's ROE is -0.13%, compared to CLPT's ROE of -1.41%. Regarding short-term risk, OFIX is less volatile compared to CLPT. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check CLPT's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, DCTH has a market cap of 363.5M. Regarding current trading prices, OFIX is priced at $9.61, while DCTH trades at $10.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas DCTH's P/E ratio is 1053.00. In terms of profitability, OFIX's ROE is -0.13%, compared to DCTH's ROE of +0.01%. Regarding short-term risk, OFIX is less volatile compared to DCTH. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check DCTH's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, VMD has a market cap of 363.4M. Regarding current trading prices, OFIX is priced at $9.61, while VMD trades at $9.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas VMD's P/E ratio is 25.62. In terms of profitability, OFIX's ROE is -0.13%, compared to VMD's ROE of +0.11%. Regarding short-term risk, OFIX is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check VMD's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, AVR has a market cap of 341.8M. Regarding current trading prices, OFIX is priced at $9.61, while AVR trades at $9.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas AVR's P/E ratio is -4.18. In terms of profitability, OFIX's ROE is -0.13%, compared to AVR's ROE of -1.24%. Regarding short-term risk, OFIX is less volatile compared to AVR. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check AVR's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, MASS has a market cap of 334.7M. Regarding current trading prices, OFIX is priced at $9.61, while MASS trades at $8.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas MASS's P/E ratio is -9.12. In terms of profitability, OFIX's ROE is -0.13%, compared to MASS's ROE of -0.26%. Regarding short-term risk, OFIX is more volatile compared to MASS. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check MASS's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, OFIX is priced at $9.61, while SMLR trades at $20.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas SMLR's P/E ratio is 3.92. In terms of profitability, OFIX's ROE is -0.13%, compared to SMLR's ROE of +0.16%. Regarding short-term risk, OFIX is more volatile compared to SMLR. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check SMLR's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, ELMD has a market cap of 305.3M. Regarding current trading prices, OFIX is priced at $9.61, while ELMD trades at $36.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas ELMD's P/E ratio is 31.51. In terms of profitability, OFIX's ROE is -0.13%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, OFIX is less volatile compared to ELMD. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check ELMD's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, SENS has a market cap of 286.6M. Regarding current trading prices, OFIX is priced at $9.61, while SENS trades at $6.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas SENS's P/E ratio is -3.48. In terms of profitability, OFIX's ROE is -0.13%, compared to SENS's ROE of -1.30%. Regarding short-term risk, OFIX is more volatile compared to SENS. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check SENS's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, CATX has a market cap of 276.2M. Regarding current trading prices, OFIX is priced at $9.61, while CATX trades at $3.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas CATX's P/E ratio is -2.54. In terms of profitability, OFIX's ROE is -0.13%, compared to CATX's ROE of -0.42%. Regarding short-term risk, OFIX is more volatile compared to CATX. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check CATX's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, OFIX is priced at $9.61, while MGRM trades at $6.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas MGRM's P/E ratio is -11.11. In terms of profitability, OFIX's ROE is -0.13%, compared to MGRM's ROE of -1.11%. Regarding short-term risk, OFIX is more volatile compared to MGRM. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check MGRM's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, SGHT has a market cap of 236.7M. Regarding current trading prices, OFIX is priced at $9.61, while SGHT trades at $4.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas SGHT's P/E ratio is -6.21. In terms of profitability, OFIX's ROE is -0.13%, compared to SGHT's ROE of -0.59%. Regarding short-term risk, OFIX is more volatile compared to SGHT. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check SGHT's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, TMCI has a market cap of 225.1M. Regarding current trading prices, OFIX is priced at $9.61, while TMCI trades at $3.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas TMCI's P/E ratio is -3.61. In terms of profitability, OFIX's ROE is -0.13%, compared to TMCI's ROE of -0.69%. Regarding short-term risk, OFIX is less volatile compared to TMCI. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check TMCI's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, OFIX is priced at $9.61, while NVRO trades at $5.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas NVRO's P/E ratio is -1.91. In terms of profitability, OFIX's ROE is -0.13%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, OFIX is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check NVRO's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, EYES has a market cap of 210M. Regarding current trading prices, OFIX is priced at $9.61, while EYES trades at $4.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas EYES's P/E ratio is N/A. In terms of profitability, OFIX's ROE is -0.13%, compared to EYES's ROE of -2.64%. Regarding short-term risk, OFIX is less volatile compared to EYES. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check EYES's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, RXST has a market cap of 204.5M. Regarding current trading prices, OFIX is priced at $9.61, while RXST trades at $4.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas RXST's P/E ratio is -4.37. In terms of profitability, OFIX's ROE is -0.13%, compared to RXST's ROE of -0.17%. Regarding short-term risk, OFIX is less volatile compared to RXST. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check RXST's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, PROF has a market cap of 196.1M. Regarding current trading prices, OFIX is priced at $9.61, while PROF trades at $6.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas PROF's P/E ratio is -5.23. In terms of profitability, OFIX's ROE is -0.13%, compared to PROF's ROE of -0.71%. Regarding short-term risk, OFIX is less volatile compared to PROF. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check PROF's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, ANIK has a market cap of 191.3M. Regarding current trading prices, OFIX is priced at $9.61, while ANIK trades at $14.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas ANIK's P/E ratio is -18.20. In terms of profitability, OFIX's ROE is -0.13%, compared to ANIK's ROE of -0.08%. Regarding short-term risk, OFIX is more volatile compared to ANIK. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check ANIK's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, OFIX is priced at $9.61, while BSGM trades at $6.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas BSGM's P/E ratio is -5.81. In terms of profitability, OFIX's ROE is -0.13%, compared to BSGM's ROE of +17.60%. Regarding short-term risk, OFIX is less volatile compared to BSGM. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check BSGM's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, EDAP has a market cap of 179.1M. Regarding current trading prices, OFIX is priced at $9.61, while EDAP trades at $4.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas EDAP's P/E ratio is -5.83. In terms of profitability, OFIX's ROE is -0.13%, compared to EDAP's ROE of -1.49%. Regarding short-term risk, OFIX is less volatile compared to EDAP. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check EDAP's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, OFIX is priced at $9.61, while MDGS trades at $2.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas MDGS's P/E ratio is -0.27. In terms of profitability, OFIX's ROE is -0.13%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, OFIX is less volatile compared to MDGS. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check MDGS's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, QTRX has a market cap of 165.1M. Regarding current trading prices, OFIX is priced at $9.61, while QTRX trades at $3.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas QTRX's P/E ratio is -1.49. In terms of profitability, OFIX's ROE is -0.13%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, OFIX is less volatile compared to QTRX. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check QTRX's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, INGN has a market cap of 164.9M. Regarding current trading prices, OFIX is priced at $9.61, while INGN trades at $6.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas INGN's P/E ratio is -6.69. In terms of profitability, OFIX's ROE is -0.13%, compared to INGN's ROE of -0.13%. Regarding short-term risk, OFIX is less volatile compared to INGN. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check INGN's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, OFIX is priced at $9.61, while QIPT trades at $3.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas QIPT's P/E ratio is -15.87. In terms of profitability, OFIX's ROE is -0.13%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, OFIX is more volatile compared to QIPT. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check QIPT's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, APYX has a market cap of 161.2M. Regarding current trading prices, OFIX is priced at $9.61, while APYX trades at $3.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas APYX's P/E ratio is -17.50. In terms of profitability, OFIX's ROE is -0.13%, compared to APYX's ROE of -0.91%. Regarding short-term risk, OFIX is more volatile compared to APYX. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check APYX's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, CVRX has a market cap of 144M. Regarding current trading prices, OFIX is priced at $9.61, while CVRX trades at $5.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas CVRX's P/E ratio is -2.70. In terms of profitability, OFIX's ROE is -0.13%, compared to CVRX's ROE of -1.21%. Regarding short-term risk, OFIX is less volatile compared to CVRX. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check CVRX's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, NNOX has a market cap of 133.6M. Regarding current trading prices, OFIX is priced at $9.61, while NNOX trades at $1.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas NNOX's P/E ratio is -1.66. In terms of profitability, OFIX's ROE is -0.13%, compared to NNOX's ROE of -0.47%. Regarding short-term risk, OFIX is less volatile compared to NNOX. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check NNOX's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, MXCT has a market cap of 131.8M. Regarding current trading prices, OFIX is priced at $9.61, while MXCT trades at $1.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas MXCT's P/E ratio is -3.42. In terms of profitability, OFIX's ROE is -0.13%, compared to MXCT's ROE of -0.22%. Regarding short-term risk, OFIX is less volatile compared to MXCT. This indicates potentially lower risk in terms of short-term price fluctuations for OFIX.Check MXCT's competition here

OFIX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OFIX stands at 392.5M. In comparison, SNWV has a market cap of 129.8M. Regarding current trading prices, OFIX is priced at $9.61, while SNWV trades at $14.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OFIX currently has a P/E ratio of -6.47, whereas SNWV's P/E ratio is 15.73. In terms of profitability, OFIX's ROE is -0.13%, compared to SNWV's ROE of -4.51%. Regarding short-term risk, OFIX is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for OFIX.Check SNWV's competition here